Skip to main navigation Skip to search Skip to main content

Responses and durability of clinical benefit in triple negative breast cancer patients treated with pegilodecakin monotherapy or in combination with platinum plus taxane-based chemotherapy

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)viii407-viii408
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
Volume29
DOIs
StatePublished - Oct 1 2018

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this